Skip to content
10-Q

Quarterly Report

Golden Ally Lifetech Group, Inc.

0001493152-22-033154

← back to feed
Filed
Nov 21, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 14, 2022 8.5B sh
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$5.24M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $1.43M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $3M
Stockholders Equity Q3 2022 · Sep 30, 2022 $4.46M
Stockholders Equity Q3 2022 · Dec 31, 2021 $2.99M
Current Liabilities Q3 2022 · Sep 30, 2022 $95.06K
Current Liabilities Q3 2022 · Dec 31, 2021 $5K
Total Liabilities Q3 2022 · Sep 30, 2022 $144.09K
Total Liabilities Q3 2022 · Dec 31, 2021 $5K
Current Assets Q3 2022 · Sep 30, 2022 $2.71M
Current Assets Q3 2022 · Dec 31, 2021 $3M
Total Assets Q3 2022 · Sep 30, 2022 $4.6M
Total Assets Q3 2022 · Dec 31, 2021 $3M
Eps Basic Q3 2022 · Sep 30, 2022 $0.00
Eps Basic Q3 2022 · Sep 30, 2022 $0.00
Sga Expense Q3 2022 · Sep 30, 2022 $54.22K
Sga Expense Q3 2022 · Sep 30, 2022 $212.27K
Rd Expense Q3 2022 · Sep 30, 2022 $18.45K
Net Income Q3 2022 · Sep 30, 2022 −$1.42M
Net Income Q3 2022 · Sep 30, 2022 −$4.99M
Operating Income Q3 2022 · Sep 30, 2022 −$1.42M
Operating Income Q3 2022 · Sep 30, 2022 −$4.99M